DK55287A - Neuritaktiverende faktor og fremgangsmaade til fremstilling deraf - Google Patents

Neuritaktiverende faktor og fremgangsmaade til fremstilling deraf

Info

Publication number
DK55287A
DK55287A DK055287A DK55287A DK55287A DK 55287 A DK55287 A DK 55287A DK 055287 A DK055287 A DK 055287A DK 55287 A DK55287 A DK 55287A DK 55287 A DK55287 A DK 55287A
Authority
DK
Denmark
Prior art keywords
neuritivative
preparing
factor
procedure
neuritivative factor
Prior art date
Application number
DK055287A
Other languages
English (en)
Other versions
DK55287D0 (da
Inventor
Denis Monard
Karen Gerrit Odink
Sergio Gloor
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868602626A external-priority patent/GB8602626D0/en
Priority claimed from GB868618760A external-priority patent/GB8618760D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK55287D0 publication Critical patent/DK55287D0/da
Publication of DK55287A publication Critical patent/DK55287A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK055287A 1986-02-04 1987-02-03 Neuritaktiverende faktor og fremgangsmaade til fremstilling deraf DK55287A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868602626A GB8602626D0 (en) 1986-02-04 1986-02-04 Neurite-promoting factor
GB868603354A GB8603354D0 (en) 1986-02-04 1986-02-11 Neurite-promoting factor
GB868618760A GB8618760D0 (en) 1986-02-04 1986-07-31 Neurite-promoting factor

Publications (2)

Publication Number Publication Date
DK55287D0 DK55287D0 (da) 1987-02-03
DK55287A true DK55287A (da) 1987-08-05

Family

ID=27262916

Family Applications (1)

Application Number Title Priority Date Filing Date
DK055287A DK55287A (da) 1986-02-04 1987-02-03 Neuritaktiverende faktor og fremgangsmaade til fremstilling deraf

Country Status (5)

Country Link
EP (1) EP0233838A3 (da)
JP (2) JP2567385B2 (da)
CA (1) CA1340855C (da)
DK (1) DK55287A (da)
PT (1) PT84237B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196196A (en) * 1986-06-03 1993-03-23 Incyte Pharmaceuticals, Inc. Use of protease nexin-I in wound dressings
US5206017A (en) * 1986-06-03 1993-04-27 Incyte Pharmaceuticals, Inc. Use of protease nexin-I as an antiinflammatory
JPH01104175A (ja) * 1986-06-03 1989-04-21 Invitron Corp 組換え精製プロテア−ゼネキシン
US5326562A (en) * 1986-06-03 1994-07-05 Incyte Pharmaceuticals, Inc. Pharmaceutical dosage unit for treating inflammation comprising protease nexin-I
US5278049A (en) * 1986-06-03 1994-01-11 Incyte Pharmaceuticals, Inc. Recombinant molecule encoding human protease nexin
US5112608A (en) * 1987-03-13 1992-05-12 Incyte Pharmaceuticals Use of protease nexin-I to mediate wound healing
US5134076A (en) * 1988-09-27 1992-07-28 The Regents Of The University Of California Monoclonal antibodies specific for protease nexin-1 and puriciation of protease nexin-1 using monoclonal antibodies
US5166317A (en) * 1988-10-31 1992-11-24 Houston Biotechnology Incorporated Neurotrophic factor
US5250414A (en) * 1988-11-04 1993-10-05 Erziehungsdirektion Of The Canton Zurich Diagnostic methods using neurite growth regulatory factors
KR100196540B1 (ko) * 1988-11-04 1999-06-15 마틴 이. 샤브 축색성장 조절인자
CA1341050C (en) * 1988-11-04 2000-07-11 Martin E. Schwab Neurite growth regulatory factors
US6071889A (en) * 1991-07-08 2000-06-06 Neurospheres Holdings Ltd. In vivo genetic modification of growth factor-responsive neural precursor cells
US7361505B1 (en) 1991-07-08 2008-04-22 Neurospheres Holdings Ltd. Multipotent neural stem cell compositions
US5980885A (en) * 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. Growth factor-induced proliferation of neural precursor cells in vivo
US7166277B1 (en) 1991-07-08 2007-01-23 Neurospheres Holdings Ltd. Remyelination of neurons using multipotent neural stem cell progeny
US6399369B1 (en) 1991-07-08 2002-06-04 Neurospheres Holdings Ltd. Multipotent neural stem cell cDNA libraries
US5750376A (en) * 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
US6294346B1 (en) 1991-07-08 2001-09-25 Neurospheres Holdings, Ltd. Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
US5851832A (en) * 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US6497872B1 (en) 1991-07-08 2002-12-24 Neurospheres Holdings Ltd. Neural transplantation using proliferated multipotent neural stem cells and their progeny
GEP20002243B (en) * 1991-09-20 2000-09-25 Amgen Inc Glial Derived Neurotrophic Factor
US5245896A (en) * 1992-08-19 1993-09-21 Kennametal Inc. Quick-change tool holder with center height adjustment mechanism
US5534615A (en) * 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
DK0755446T3 (da) * 1994-04-25 2007-01-29 Genentech Inc Cardiotrophin og anvendelser deraf
US6472585B1 (en) 1994-04-25 2002-10-29 Genentech, Inc. Cardiotrophin-1 defective mouse
US7258983B2 (en) 1994-04-25 2007-08-21 Genentech, Inc. Cardiotrophin-1 compositions and methods for the treatment of tumor
CA2200709A1 (en) * 1994-09-23 1996-03-28 Samuel Weis In vitro models of cns function and dysfunction
US7544511B2 (en) 1996-09-25 2009-06-09 Neuralstem Biopharmaceuticals Ltd. Stable neural stem cell line methods
PL204293B1 (pl) 1998-11-06 2009-12-31 Univ Zuerich Oczyszczone białko i jego zastosowanie, izolowany kwas nukleinowy, wektor do klonowania, rekombinowana komórka, sposób wytwarzania rekombinowanego białka, sposób identyfikacji rybozymu lub antysensownego kwasu nukleinowego, przeciwciało monoklonalne, zastosowanie przeciwciała, sposób wytwarzania przeciwciał poliklonalnych, izolowana próbka surowicy odpornościowej, zastosowanie surowicy odpornościowej i sposób wytwarzania przeciwciał monoklonalnych.
US8293488B2 (en) 2002-12-09 2012-10-23 Neuralstem, Inc. Method for screening neurogenic agents
US20040185429A1 (en) 2002-12-09 2004-09-23 Judith Kelleher-Andersson Method for discovering neurogenic agents
PL1758986T3 (pl) 2004-06-09 2016-03-31 Univ Court Univ Of Edinburgh Nerwowe komórki macierzyste
IN2014CN03629A (da) 2004-11-17 2015-09-04 Neuralstem Inc
WO2010075500A1 (en) 2008-12-23 2010-07-01 Stemcells California, Inc Target populations of oligodendrocyte precursor cells and methods of making and using same
US9540611B2 (en) 2010-07-28 2017-01-10 Neuralstem, Inc. Methods for treating and/or reversing neurodegenerative diseases and/or disorders
KR20140030023A (ko) 2012-08-29 2014-03-11 삼성전자주식회사 조리장치 및 그 제어방법
CA2964927C (en) 2014-10-20 2019-07-30 Neuralstem, Inc. Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof

Also Published As

Publication number Publication date
JPH0998791A (ja) 1997-04-15
JP2567385B2 (ja) 1996-12-25
EP0233838A3 (en) 1990-01-31
JP2882775B2 (ja) 1999-04-12
JPS62223194A (ja) 1987-10-01
CA1340855C (en) 1999-12-21
PT84237A (en) 1987-03-01
PT84237B (pt) 1989-09-14
DK55287D0 (da) 1987-02-03
EP0233838A2 (en) 1987-08-26

Similar Documents

Publication Publication Date Title
DK55287D0 (da) Neuritaktiverende faktor og fremgangsmaade til fremstilling deraf
DK664887D0 (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK3687A (da) Polypeptider og fremgangsmaade til fremstilling deraf
DK522487D0 (da) Imidazopyridinforbindelse og fremgangsmaade til fremstilling deraf
DK256485A (da) Veterinaert praeparat og fremgangsmaade til fremstilling deraf
DK521887D0 (da) Substituerede pyrazoliner og fremgangsmaade til fremstilling deraf
DK491087D0 (da) Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf
DK159288D0 (da) Saccharidblanding og fremgangsmaade til fremstilling deraf
DK35687A (da) Isoquinolinderivater og fremgangsmaade til fremstilling deraf
DK315085A (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK355387D0 (da) Overtraekspraeparat og fremgangsmaade til anvendelse deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK225788D0 (da) Poroes harpiksfilm og fremmgangsmaade til fremstilling deraf
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK251087A (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
DK487688A (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK26384D0 (da) Toxoplasmosefaktor og fremgangsmade til fremstilling deraf
DK624588D0 (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
DK129689A (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
DK160087A (da) Katalysatorkomponent og fremgangsmaade til fremstilling deraf
DK485988A (da) Bovint placentrat lactogen og fremgangsmaade til fremstilling deraf
DK290187D0 (da) Peptidderivater og fremgangsmaade til fremstilling deraf
DK552284A (da) 2-chlor-3-trifluormethylbenzaldehyd og fremgangsmaade til fremstilling deraf
DK319188D0 (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
DK287787D0 (da) Isoxazolidinonderivater og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment